124 related articles for article (PubMed ID: 12436459)
1. Optimal designs of two-stage studies for estimation of sensitivity, specificity and positive predictive value.
McNamee R
Stat Med; 2002 Dec; 21(23):3609-25. PubMed ID: 12436459
[TBL] [Abstract][Full Text] [Related]
2. Designing 2-phase prevalence studies in the absence of a "gold standard" test.
Salim A; Welsh AH
Am J Epidemiol; 2009 Aug; 170(3):369-78. PubMed ID: 19505999
[TBL] [Abstract][Full Text] [Related]
3. Two-phase sampling for simultaneous prevalence estimation and case detection.
McNamee R
Biometrics; 2004 Sep; 60(3):783-92. PubMed ID: 15339302
[TBL] [Abstract][Full Text] [Related]
4. Optimal experiment design for cardinal values estimation: guidelines for data collection.
Bernaerts K; Gysemans KP; Nhan Minh T; Van Impe JF
Int J Food Microbiol; 2005 Apr; 100(1-3):153-65. PubMed ID: 15854701
[TBL] [Abstract][Full Text] [Related]
5. Estimating sensitivity and specificity from positive predictive value, negative predictive value and prevalence: application to surveillance systems for hospital-acquired infections.
Kelly H; Bull A; Russo P; McBryde ES
J Hosp Infect; 2008 Jun; 69(2):164-8. PubMed ID: 18448199
[TBL] [Abstract][Full Text] [Related]
6. Including sampling and phenotyping costs into the optimization of two stage designs for genomewide association studies.
Müller HH; Pahl R; Schäfer H
Genet Epidemiol; 2007 Dec; 31(8):844-52. PubMed ID: 17549751
[TBL] [Abstract][Full Text] [Related]
7. Prospective studies of diagnostic test accuracy when disease prevalence is low.
Obuchowski NA; Zhou XH
Biostatistics; 2002 Dec; 3(4):477-92. PubMed ID: 12933593
[TBL] [Abstract][Full Text] [Related]
8. Efficiency of two-phase designs for prevalence estimation.
McNamee R
Int J Epidemiol; 2003 Dec; 32(6):1072-8. PubMed ID: 14681277
[TBL] [Abstract][Full Text] [Related]
9. [Modelling sensitivity, specificity and predictive values of hematuria testing using reagent sticks in the diagnosis of Schistosoma haematobium infection].
Etard JE
Bull Soc Pathol Exot; 2004 Feb; 97(1):24-8. PubMed ID: 15104153
[TBL] [Abstract][Full Text] [Related]
10. Optimal and minimax three-stage designs for phase II oncology clinical trials.
Chen K; Shan M
Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of efficient designs for observational epidemiologic studies.
Kalish LA; Begg CB
Biometrics; 1987 Mar; 43(1):145-67. PubMed ID: 3567303
[TBL] [Abstract][Full Text] [Related]
12. Optimal robust two-stage designs for genome-wide association studies.
Nguyen TT; Pahl R; Schäfer H
Ann Hum Genet; 2009 Nov; 73(Pt 6):638-51. PubMed ID: 19839987
[TBL] [Abstract][Full Text] [Related]
13. [Comparison between OptiMAL and the thick smear tests for malaria diagnosis in an endemic area during a non-epidemic period].
Londoño B; Carmona J; Blair S
Biomedica; 2002 Dec; 22(4):466-75. PubMed ID: 12596444
[TBL] [Abstract][Full Text] [Related]
14. Incorporating the sampling variation of the disease prevalence when calculating the sample size in a study to determine the diagnostic accuracy of a test.
Yi Q; Panzarella T; Corey P
Control Clin Trials; 2004 Aug; 25(4):417-27. PubMed ID: 15296816
[TBL] [Abstract][Full Text] [Related]
15. Two-stage designs applying methods differing in costs.
Goll A; Bauer P
Bioinformatics; 2007 Jun; 23(12):1519-26. PubMed ID: 17463029
[TBL] [Abstract][Full Text] [Related]
16. Derivation and validation of diabetes risk score for urban Asian Indians.
Ramachandran A; Snehalatha C; Vijay V; Wareham NJ; Colagiuri S
Diabetes Res Clin Pract; 2005 Oct; 70(1):63-70. PubMed ID: 16126124
[TBL] [Abstract][Full Text] [Related]
17. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
[TBL] [Abstract][Full Text] [Related]
18. Avoiding verification bias in screening test evaluation in resource poor settings: a case study from Zimbabwe.
Gaffikin L; McGrath J; Arbyn M; Blumenthal PD
Clin Trials; 2008; 5(5):496-503. PubMed ID: 18827042
[TBL] [Abstract][Full Text] [Related]
19. Estimating population size with two- and three-stage sampling designs.
Tate JE; Hudgens MG
Am J Epidemiol; 2007 Jun; 165(11):1314-20. PubMed ID: 17400569
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic properties of nerve conduction tests in population-based carpal tunnel syndrome.
Atroshi I; Gummesson C; Johnsson R; Ornstein E
BMC Musculoskelet Disord; 2003 May; 4():9. PubMed ID: 12734018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
